Rheumatology Department - LUHFT wide
What is an undifferentiated connective tissue disease?
Your immune system normally protects you from infections. It does this by making antibodies that fight harmful bacteria and viruses. Sometimes the immune system attacks the body’s own tissues instead. This causes inflammation and is called autoimmunity.
Undifferentiated Connective Tissue Disease (UCTD) is one such autoimmune condition. It is called “undifferentiated” because the features do not exactly match one specific connective tissue disease, like lupus, systemic sclerosis, myositis or Sjögren’s disease.
“Connective tissue” is the body’s framework. It includes:
• Joints
• Muscles
• Skin
• Cartilage
• Organs such as the lungs, kidneys, and heart.
In UCTD, inflammation can affect these tissues in different ways.
What is an Autoantibody?
An autoantibody is a protein your immune system makes that attacks your own body. They can be a sign of an autoimmune disease. However, they can also appear for a short time due to an infection, hormonal changes such as pregnancy, or certain medications. Having autoantibodies alone does not mean you have an autoimmune disease.
How common is it?
UCTD is fairly common in rheumatology clinics.
Who develops UCTD?
• Gender: More common in women.
• Age: Usually between the ages of 30 and 55, but it can occur at any age.
• Children: Rarely affected.
What causes UCTD?
The exact cause is unknown. Genes play a role, and some people inherit immune system traits that increase the risk. No single environmental cause has been proven.
What are the symptoms?
Symptoms can be different for everyone and may come and go. Tiredness (fatigue) and pain are often the most common symptoms.
Common symptoms include:
• General: tiredness, weight loss, low fevers.
• Joints and muscles: pain, swelling, weakness.
• Skin and mouth: rashes, ulcers, dry eyes, dry mouth, sensitivity to sunlight.
• Circulation: Raynaud’s phenomenon (fingers or toes turning white, blue, then red
in cold).
• Digestive system: heartburn, difficulty swallowing.
• Chest: shortness of breath, cough, chest pain.
• Other: swollen lymph nodes.
How is UCTD diagnosed?
Diagnosis can be challenging because symptoms overlap with other autoimmune diseases. There is no single test. Diagnosis is based on a combination of findings.
A rheumatologist usually makes the diagnosis based on:
• A detailed history of your symptoms.
• A physical examination.
• Urine tests if required.
• Blood tests to look for autoantibodies.
• Scans or other tests if needed to check your organs like your lungs or heart,
Can UCTD change into another condition?
Yes. About one-third of people with UCTD may develop a condition, such as lupus, Sjögren’s, myositis or systemic sclerosis This usually happens within three- five years of diagnosis.
However, the longer you have had an UCTD that has been stable, the less likely it is to progress. If you are not on long-term medication and your condition has been stable for a significant period, your doctor may consider discharging you from the clinic as the risk of a serious problem developing is very low.
How is UCTD treated?
There is no cure, but treatments can control symptoms and prevent complications. The choice of treatment depends on which symptoms and organs are involved.
Treatment options include:
• Pain and inflammation relief:
o NSAIDs (e.g., ibuprofen) for joint and muscle pain.
o Corticosteroids (e.g., prednisolone) for inflammation.
• Immune system medicines:
o Hydroxychloroquine for rashes, joint pain, ulcers, and fatigue
o Immunosuppressants (e.g., methotrexate, azathioprine) if symptoms are severe
• Managing specific problems:
o Reflux: lifestyle changes, omeprazole, lansoprazole, or antacids.
o Raynaud’s: keeping warm, silver gloves, medication such as nifedipine or losartan.
o Rashes: steroid creams.
• Non-drug support:
o Physiotherapy to maintain movement and strength.
o Balanced rest and exercise.
It is important to note that not all medications used to manage the symptoms of UCTD have a license for use in this condition, and the supporting evidence is limited. Your doctor will discuss the potential benefits and risks of any treatment with you.
What is the outlook (prognosis)?
The outcome depends on symptoms and which organs are affected.
• Many people have a mild illness and manage well with treatment.
• Some may later develop a defined connective tissue disease.
• UCTD can occasionally affect organs such as the lungs, if your rheumatologist thinks that you are at risk of this, they will discuss how they will monitor for this.
• You may be very symptomatic, but the disease itself is considered a milder form of an autoimmune condition. It is perfectly normal to feel worried and uncertain, and it is important to seek support.
• In some cases if your disease has been very stable for a number of years your rheumatologist may discharge you but also educate you any symptoms to look out for which might mean they need to see you back in clinic.
Feedback
Your feedback is important to us and helps us influence care in the future.
Following your discharge from hospital or attendance at your outpatient appointment you will receive a text asking if you would recommend our service to others. Please take the time to text back, you will not be charged for the text and can opt out at any point. Your co-operation is greatly appreciated.
Further information
Rheumatology Specialist Nurses
Telephone: 0151 529 3706/3034
Text phone number: 18001 0151 529 3709/ 3034
Author: Rheumatology department
Review date: February 2029
PI 3227 V1